| Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury MJ Overman, DM Maru, C Charnsangavej, EM Loyer, H Wang, P Pathak, ... J Clin Oncol 28 (15), 2549-2555, 2010 | 246 | 2010 |
| The role of systemic chemotherapy and multidisciplinary management in improving the overall survival of patients with metastatic squamous cell carcinoma of the anal canal C Eng, GJ Chang, YN You, P Das, M Rodriguez-Bigas, Y Xing, ... Oncotarget 5 (22), 11133, 2014 | 126 | 2014 |
| Durable complete responses in metastatic colorectal cancer treated with chemotherapy alone R Ferrarotto, P Pathak, D Maru, A Agarwal, M Overman, PM Hoff, ... Clinical colorectal cancer 10 (3), 178-182, 2011 | 85 | 2011 |
| V‐CLIP: integrating plasma vascular endothelial growth factor into a new scoring system to stratify patients with advanced hepatocellular carcinoma for clinical trials AO Kaseb, MM Hassan, E Lin, L Xiao, V Kumar, P Pathak, R Lozano, ... Cancer 117 (11), 2478-2488, 2011 | 55 | 2011 |
| Liposomal vincristine for relapsed or refractory Ph-negative acute lymphoblastic leukemia: a review of literature P Pathak, R Hess, MA Weiss Therapeutic Advances in Hematology 5 (1), 18-24, 2014 | 32 | 2014 |
| Treatment options in metastatic squamous cell carcinoma of the anal canal C Eng, P Pathak Current treatment options in oncology 9, 400-407, 2008 | 24 | 2008 |
| The treatment of metastatic squamous cell carcinoma (SCCA) of the anal canal: a single institution experience P Pathak, BT King, A Ohinata, P Das, CH Crane, JL Chase, C Eng Gastrointestinal cancer symposium, ASCO, 352, 2008 | 13 | 2008 |
| The use of 5-fluorouracil and oxaliplatin (FOLFOX) for colorectal cancer is associated with the development of splenomegaly and thrombocytopenia S Politano, P Pathak, PM Hoff, C Charnsangavej, MJ Overman, E Loyer, ... Journal of Clinical Oncology 26 (15_suppl), 4102-4102, 2008 | 7 | 2008 |
| Second-line chemotherapy use in metastatic colon cancer varies by disease responsiveness S Politano, M Overman, P Pathak, R Chadha, K Glover, DZ Chang, ... Clinical colorectal cancer 7 (1), 55-59, 2008 | 7 | 2008 |
| Serum CA 19–9 level as a surrogate marker for prognosis in locally advanced pancreatic cancer (LAPC) DR Fogelman, P Pathak, W Qiao, R Chadha, J Jhamb, D Melisi, RA Wolff, ... Journal of Clinical Oncology 26 (15_suppl), 15514-15514, 2008 | 6 | 2008 |
| Demodex folliculorum infestation mimicking acute cutaneous GVHD S Tahir, J Vadakara, J Lynch, B Andrick, P Pathak, E Hossler, N Sebes, ... Biology of Blood and Marrow Transplantation 26 (3), S342, 2020 | 1 | 2020 |
| S2991 Gastric Myeloid Sarcoma as a Presentation of Relapsed Acute Myelomonocytic Leukemia-A Case Report M Makary, J Vadakara, S Tahir, RN Shah, DM Deivert, S Hosur, F Absar, ... Official journal of the American College of Gastroenterology| ACG 115, S1575, 2020 | | 2020 |
| Vitamin K Deficiency in the Hospitalized Patient-- Are we Underestimating the Prevalence? P Pathak Journal of Blood & Lymph 5, e117, 2015 | | 2015 |
| Mantle Cell Lymphoma: Outcomes after Hematopoietic Stem Cell Transplantation P Pathak, SV Kumar, O Alpdogan, M Carabasi, N Flomenberg, D Grosso, ... Biology of Blood and Marrow Transplantation 21 (2), S202, 2015 | | 2015 |
| Association of exogenous hormonal intake with the risk of development of hepatocellular carcinoma in women P Pathak Texas Medical Center Dissertations, 2010 | | 2010 |
| GIANT CELL CARCINOMA OF PANCREAS: MD ANDERSON EXPERIENCE SV Kumar, R Morey, P Pathak, D Fogelman, RA Wolff, M Javle Pancreas 37 (4), 478, 2008 | | 2008 |
| The use of biologic therapy in the treatment of unresectable appendiceal neoplasms RT Shroff, BT King, P Pathak, LA Lambert, MJ Overman, RA Wolff, ... ASCO, 15546, 2008 | | 2008 |
| Second-line chemotherapy utilization in metastatic colorectal cancer may vary by disease responsiveness S Kopetz, P Pathak, R Chadha, MJ Overman, C Eng, Glover, K Y, ... Gastrointestinal cancer symposium, ASCO, 313, 2007 | | 2007 |
